Date: April 21, 2020
Time: 11:30 am–12:30 pm Eastern/8:30–9:30 am Pacific
Location: Webinar (Access instructions e-mailed upon registration)
By April 15, 2020, the USPTO will rule on the first-ever challenge to a microbiome therapeutics patent in the U.S.—Genome & Co. v. University of Chicago.
Join us on April 21 for a webinar presented by Mark FitzGerald, a partner at Nixon Peabody, and members of the HGF Microbiome IP Team. Mark will examine the ruling and its impact on patents covering microbiome therapeutics in the U.S., and the HGF Microbiome IP team will provide perspective regarding challenges to patents covering similar subject matter in the European Patent Office.
This course is eligible for 1.0 credit. Click here for continuing education details.